No New Safety Signals With Ruxolitinib Cream Used in Combination With Systemic Therapies for Atopic Dermatitis: A Multicenter Retrospective Study

Journal of the American Academy of Dermatology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles